These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15227959)

  • 1. [Pathologic conditions associated with drug-induced rhinitis].
    Milosević D; Janosević L; Dergenc R; Vasić M
    Srp Arh Celok Lek; 2004; 132(1-2):14-7. PubMed ID: 15227959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
    Tarchalska B; Gotlib T; Samoliński B
    Pol Merkur Lekarski; 2005 Sep; 19(111):288-90. PubMed ID: 16358845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The rebound of nasal resistance after decongestant used in nose].
    Shen J; Huang X; Xiang J; Shu H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical review of 33 cases of rhinitis medicamentosa by decongestant nasal spray].
    Yuta A; Ogawa Y
    Arerugi; 2013 Dec; 62(12):1623-30. PubMed ID: 24608651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhinitis medicamentosa: the forgotten factor in nasal obstruction.
    Mabry RL
    South Med J; 1982 Jul; 75(7):817-9. PubMed ID: 6178170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhinitis medicamentosa: what an otolaryngologist needs to know.
    Doshi J
    Eur Arch Otorhinolaryngol; 2009 May; 266(5):623-5. PubMed ID: 19096862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM; Hallén H
    Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhinitis medicamentosa.
    Toohill RJ; Lehman RH; Grossman TW; Belson TP
    Laryngoscope; 1981 Oct; 91(10):1614-21. PubMed ID: 6169966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.
    Cam B; Sari M; Midi A; Gergin O
    Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3123-3130. PubMed ID: 31468129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal septal perforation secondary to rhinitis medicamentosa.
    Keyserling HF; Grimme JD; Camacho DL; Castillo M
    Ear Nose Throat J; 2006 Jun; 85(6):376, 378-9. PubMed ID: 16866112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists.
    Fowler J; Chin CJ; Massoud E
    J Otolaryngol Head Neck Surg; 2019 Dec; 48(1):70. PubMed ID: 31818321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predisposing factors of rhinitis medicamentosa: what can influence drug discontinuation?
    De Corso E; Mastrapasqua RF; Tricarico L; Settimi S; Di Cesare T; Mele DA; Trozzi L; Salonna G; Paludetti G; Galli J
    Rhinology; 2020 Jun; 58(3):233-240. PubMed ID: 31904029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
    Bielenberg J
    Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
    [No Abstract]   [Full Text] [Related]  

  • 17. Rhinitis medicamentosa.
    Black MJ; Remsen KA
    Can Med Assoc J; 1980 Apr; 122(8):881-4. PubMed ID: 6154514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.
    Mortuaire G; de Gabory L; François M; Massé G; Bloch F; Brion N; Jankowski R; Serrano E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):137-44. PubMed ID: 23375990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical hyaluronic acid in rhinitis medicamentosa: could our perspective be changed?
    Casale M; Vella P; Moffa A; Sabatino L; Rinaldi V; Grimaldi V; Salvinelli F
    J Biol Regul Homeost Agents; 2017 Dec; 31(4 Suppl 2):55-62. PubMed ID: 29202563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced rhinitis.
    Varghese M; Glaum MC; Lockey RF
    Clin Exp Allergy; 2010 Mar; 40(3):381-4. PubMed ID: 20210811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.